Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DoMy Study: Mifepristone dose comparison for pain in early medical abortion
2017-004083-35Phase 3Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mifepristone in pregnancy (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Hourly pain intensity for 5 hours after misoprostol intake. Started Feb 2018; status: completed.
02
Drugs
mifepristone
03
Conditions
pregnancy
Beyond the preview
Go deeper on 2017-004083-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004083-35.